Dergiler / Klinik Psikofarmakoloji Bülteni / 2015 / Cilt: 25 - Sayı: 4

Frequency of Synthetic Cannabinoid Use and Its Relationship with Socio-Demographic Characteristics and Treatment Outcomes in Alcohol- and Substance- Dependent Inpatients: A retrospective study

Sayfa
348–354
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusions: In conclusion, the socio-demographic characteristics can be included as predictive factors for SC use

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The recent emergence of Synthetic Cannabinoids (SCs) has become a serious public health problem.
📊
Temel Bulgular & Veri:Methods: We retrospectively analyzed medical records of 323 inpatients that were treated at the alcohol and substance dependence treatment center between January 2012 and December 2013.
💡
Sonuç & Katkı:Conclusions: In conclusion, the socio-demographic characteristics can be included as predictive factors for SC use
🔬Tür:Araştırma Makalesi
📍Kapsam:2012 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: The recent emergence of Synthetic Cannabinoids (SCs) has become a serious public health problem. Here we aimed to analyze the frequency of SC use and its relationship with sociodemographic characteristics and treatment outcomes in alcohol- and substance-dependent inpatients retrospectively. Methods: We retrospectively analyzed medical records of 323 inpatients that were treated at the alcohol and substance dependence treatment center between January 2012 and December 2013. The data were extracted from patient records. Results: The mean age of SC users was lower than for patients without a history of SC use. The mean duration of education was shorter for SC users. Age at first drug use of SC users was lower, numbers of hospitalizations were lower and duration of substance use was shorter in SC users compared with the other substance user groups. The rate of legal issues was higher in the SC-use group. The rate of lapse and the rate of dropout was higher in patients with SC use than in other substance users (for all p< 0.05). Age, age at first substance use, duration of use (years) and criminal records were predicted as determining variables for SC use in inpatients. Conclusions: In conclusion, the socio-demographic characteristics can be included as predictive factors for SC use

🔖

Bu Makaleye Atıf Yap

YİLMAZ, O., NURMEDOV, S., DARCİN, A. E., NOYAN, O. C., DİLBAZ, N. (2022). Frequency of Synthetic Cannabinoid Use and Its Relationship with Socio-Demographic Characteristics and Treatment Outcomes in Alcohol- and Substance- Dependent Inpatients: A retrospective study. Klinik Psikofarmakoloji Bülteni, Cilt: 25 - Sayı: 4, 348–354. https://ajindex.com/articles/573948

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Tellioglu T, Celebi F. Synthetic marijuana: a recent turmoil in substance abuse. Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2014
  2. 24(4):396-404. [CrossRef] 2. Showalter VM, Compton DR, Martin BR, Abood ME. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 1996
  3. 278(3):989-99. 3. Wintermeyer A, Moller I, Thevis M, Jubner M, Beike J, Rothschild MA, et al. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018. Anal Bioanal Chem 2010
  4. 398(5):2141-53. [CrossRef] 4. Gunduz Y, Soyata AZ. Delusional rape thoughts induced by synthetic cannabinoids: report of two cases. Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2014
  5. 24(Suppl.1):S278. 5. Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid and marijuana exposures reported to poison centers. Hum Exp Toxicol 2012
  6. 31(10)1006-11. [CrossRef] 6. Seely KA, Lapoint J, Moran JH, Fattore L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 2012
  7. 39(2):234-43. [CrossRef] 7. Fantegrossi WE, Moran JH, Radominska-Pandya A, Prather PL. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to ?(9)-THC: mechanism underlying greater toxicity? Life Sci 2014
  8. 97(1):45-54. [CrossRef] 8. Papanti D, Schifano F, Botteon G, Bertossi F, Mannix J, Vidoni D, et al. "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report. Hum Psychopharmacol 2013
  9. 28(4):379-89. [CrossRef] 9. Hu X, Primack BA, Barnett TE, Cook RL. College students and use of K2: an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy 2011
  10. 6(16):18-22. [CrossRef] 10. Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of spice products (synthetic cannabinoids). Drug Alcohol Depend 2012
  11. 120(1-3):238-41. [CrossRef] 11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition. Text revision. Washington: American Psychiatric Association, 2000. 12. Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 2014
  12. 144(1)12-41. [CrossRef] 13. Elsohly MA, Gul W, Wanas AS, Radwan MM. Synthe